Krish Sundaresan is the General Manager and Managing Director of Pfizer Hong Kong where he manages the biopharmaceutical portfolio in core therapeutic areas including vaccines, medicines for oncology, inflammation and immunology, rare diseases, anti-infectives and internal medicine. Prior to his appointment in Pfizer Hong Kong, Krish has held multiple leadership roles in Pfizer India as well as other MNCs including Novartis and J&J. Krish has 15+ years of experience in healthcare across Pharmaceuticals, Medical Devices and Hospitals with MNCs and start-ups and 7+ years in technology across Asia Pacific and the USA. Krish is a firm believer of public-private partnerships to drive growth, improve health equity and access to innovative care. He has been an active member of AmCham HK since April 2022, in particular, the Healthcare & Pharmaceuticals Committee. On 30 August 2022, he was voted as the Vice Chair of the Digital Health subcommittee. With Krish’s deep expertise in healthcare, digital innovation and strong networks, he will be able to contribute extensively to the AmCham Board of Governors.